FDA Panel Wants a Closer Look at St. Jude Medical Heart Implant

Published: May 29, 2012

An FDA advisory panel recommended taking a closer look at safety data from St. Jude Medical's Amplatzer heart implant, now that more is known about the device after more than a decade on the market. An FDA panel recommended that the agency's Center for Devices & Radiological Health re-analyze existing data for St. Jude Medical's (NYSE:STJ) Amplatzer heart implant during a hearing yesterday to review safety data for the Amplatzer and for W.L. Gore & Associates' Helex implant.

Back to news